590 active trials 298 recruiting 58 Phase 3 324 sponsors 79 changes in 30 days
| Early Phase 1 | 17 | |
| Phase 1 | 93 | |
| Phase 1/2 | 71 | |
| Phase 2 | 193 | |
| Phase 2/3 | 8 | |
| Phase 3 | 50 | |
| Phase 4 | 19 |
| NCT ID | Title | Sponsor | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06072482 | A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis | Amgen | Recruiting | 2026-08-14 |
| NCT07689578 | Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant… | Turun Song | Recruiting | 2026-08-05 |
| NCT06722586 | Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related… | Peking University First Hospital | Recruiting | 2026-06-30 |
| NCT07216014 | Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety | Sixth Affiliated Hospital, Sun Yat-sen University | Recruiting | 2026-04-24 |
| NCT07158814 | Safety of RSV Preventive Monoclonal Antibody | Duke University | Recruiting | 2026-03-16 |
| NCT07355699 | Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously… | Beijing Tongren Hospital | Recruiting | 2026-01-21 |
| NCT07135427 | Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency | University of Alabama at Birmingham | Recruiting | 2025-11-10 |
| NCT05849740 | An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined… | Institute of Hematology & Blood Diseases Hospital, China | Recruiting | 2025-08-05 |
| NCT06930573 | A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular… | The First Affiliated Hospital of Zhengzhou University | Recruiting | 2025-04-16 |
| NCT07693166 | Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF | University of British Columbia | Not Yet Recruiting | 2026-07-09 |
| NCT07653516 | Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness | Insel Gruppe AG, University Hospital Bern | Not Yet Recruiting | 2026-07-01 |
| NCT07674368 | Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed | Hunan Cancer Hospital | Not Yet Recruiting | 2026-07-01 |
| NCT04101838 | B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults | University of Alabama at Birmingham | Active, Not Recruiting | 2026-05-14 |
| NCT07554014 | A Single-center, Prospective, Self-controlled, Observational Real-world Study of the… | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not Yet Recruiting | 2026-04-28 |
| NCT07109297 | Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in… | Sanofi | Active, Not Recruiting | 2026-03-23 |
| NCT07051070 | Efficacy and Safety of Rituximab in the Treatment of Anti-Vimentin Antibody-associated… | Xuanwu Hospital, Beijing | Not Yet Recruiting | 2025-07-03 |
| NCT06825312 | Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies… | Liaoning Chengda Biotechnology CO., LTD | Active, Not Recruiting | 2025-03-11 |
| NCT06678373 | Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in… | Liaoning Chengda Biotechnology CO., LTD | Active, Not Recruiting | 2024-12-13 |
| NCT06653907 | Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference… | Yang ZHANG | Not Yet Recruiting | 2024-10-23 |
| Phase 3 | ||||
| NCT06152575 | MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People… | Pfizer | Recruiting | 2026-08-24 |
| NCT05199688 | A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And… | Hoffmann-La Roche | Recruiting | 2026-08-11 |
| NCT07258511 | A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3… | Janssen Research & Development, LLC | Recruiting | 2026-07-31 |
| NCT06182774 | Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older… | Canadian Cancer Trials Group | Recruiting | 2026-07-14 |
| NCT07689630 | Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Recruiting | 2026-07-08 |
| NCT06794086 | SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases | Jun Huang | Recruiting | 2026-06-30 |
Sun Yat-sen University (25) · Institute of Hematology & Blood Diseases Hospital, China (22) · Sichuan Baili Pharmaceutical Co., Ltd. (20) · Fudan University (11) · Assistance Publique - Hôpitaux de Paris (8) · Ruijin Hospital (8) · Shanghai Zhongshan Hospital (8) · City of Hope Medical Center (7) · Janssen Research & Development, LLC (7) · Tianjin Medical University Cancer Institute and Hospital (7)